{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:42Z","timestamp":1789524162025,"version":"build-2803163510"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Patients with COVID-19 often have hypoxemia, impaired lung function, and abnormal imaging manifestations in acute and convalescent stages. Alveolar inflammation, pulmonary vasculitis, and thromboembolism synergistically damage the blood-air barrier, resulting in increased pulmonary permeability and gas exchange disorders. The incidence of low platelet counts correlates with disease severity. Platelets are also involved in the impairment of pulmonary microcirculation leading to abnormal lung function at different phases of COVID-19. Activated platelets lose the ability to protect the integrity of blood vessel walls, increasing the permeability of pulmonary microvasculature. High levels of platelet activation markers are observed in both mild and severe cases, short and long term. Therefore, the risk of thrombotic events may always be present. Vascular endothelial injury, immune cells, inflammatory mediators, and hypoxia participate in the high reactivity and aggregation of platelets in various ways. Microvesicles, phosphatidylserine (PS), platelets, and coagulation factors are closely related. The release of various cell-derived microvesicles can be detected in COVID-19 patients. In addition to providing a phospholipid surface for the synthesis of intrinsic factor Xase complex and prothrombinase complex, exposed PS also promotes the decryption of tissue factor (TF) which then promotes coagulant activity by complexing with factor VIIa to activate factor X. The treatment of COVID-19 hypercoagulability and thrombosis still focuses on early intervention. Antiplatelet therapy plays a role in relieving the disease, inhibiting the formation of the hypercoagulable state, reducing thrombotic events and mortality, and improving sequelae. PS can be another potential target for the inhibition of hypercoagulable states.<\/jats:p>","DOI":"10.3389\/fimmu.2022.955654","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:24:37Z","timestamp":1664465077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors"],"prefix":"10.3389","volume":"13","author":[{"given":"Mengqi","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langjiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa632","article-title":"Clinical features and outcomes of 105 hospitalized patients with COVID-19 in Seattle, Washington","volume":"71","author":"Buckner","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2001217","DOI":"10.1183\/13993003.01217-2020","article-title":"Abnormal pulmonary function in COVID-19 patients At time of hospital discharge","volume":"55","author":"Mo","year":"2020","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12931-020-01429-6","article-title":"Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase","volume":"21","author":"Huang","year":"2020","journal-title":"Respir Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01755-4","article-title":"1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study","volume":"398","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32656-","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: A cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/annrheumdis-2020-218323","article-title":"Preliminary predictive criteria for COVID-19 cytokine storm","volume":"80","author":"Caricchio","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine storms: Understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflammation Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13045-020-01003-z","article-title":"Thrombocytopenia and thrombosis in hospitalized patients with COVID-19","volume":"13","author":"Mei","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15534","article-title":"Platelets contribute to disease severity in COVID-19","volume":"19","author":"Barrett","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02290-6","article-title":"Immature platelets in patients hospitalized with covid-19","volume":"51","author":"Cohen","year":"2021","journal-title":"J Thromb Thromb"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17656","article-title":"Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients","volume":"194","author":"Welder","year":"2021","journal-title":"Br J Haematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145168","article-title":"Covid-19: The rollercoaster of Fibrin(Ogen), d-dimer, Von willebrand factor, p-selectin and their interactions with endothelial cells, platelets and erythrocytes","volume":"21","author":"Grobler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jth.1484","article-title":"Thrombocytopenia and its association with mortality in patients with COVID-19","volume":"18","author":"Yang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: A retrospective cohort study","volume":"7","author":"Liao","year":"2020","journal-title":"Lancet Haematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16885","article-title":"Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19)","volume":"190","author":"Chen","year":"2020","journal-title":"Br J Haematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15267","article-title":"Prolonged elevation of d-dimer levels in convalescent COVID-19 patients is independent of the acute phase response","volume":"19","author":"Townsend","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00020-0","article-title":"Do vaccines protect from long COVID","volume":"10","author":"Venkatesan","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-03495-2","article-title":"Do vaccines protect against long COVID? what the data say","volume":"599","author":"Ledford","year":"2021","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7326\/L21-0244","article-title":"Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine","volume":"174","author":"Sangli","year":"2021","journal-title":"Ann Intern Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1931","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: Self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2106075","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination - response from the manufacturer","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1538-7836.2011.04317.x","article-title":"How platelets safeguard vascular integrity","author":"Ho-Tin-No\u00e9","year":"2011","journal-title":"J Thromb Haemost"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003442","article-title":"Platelets docking to vWF prevent leaks during leukocyte extravasation by stimulating tie-2","volume":"136","author":"Braun","year":"2020","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183752","article-title":"Platelets in lung biology","volume":"75","author":"Weyrich","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V22.1.82.82","article-title":"Megakaryocytes in the pulmonary circulation","volume":"22","author":"TM","year":"1963","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.exphem.2018.04.001","article-title":"The physical and cellular conditions of the human pulmonary circulation enable thrombopoiesis","volume":"63","author":"Ouzegdouh","year":"2018","journal-title":"Exp Hematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(82)90163-3","article-title":"Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation","volume":"28","author":"Trowbridge","year":"1982","journal-title":"Thromb Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2021.09.005","article-title":"Interaction of the inflammatory response and megakaryocytes in COVID-19 infection","volume":"104","author":"Battina","year":"2021","journal-title":"Exp Hematol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00018-022-04318-x","article-title":"Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19","volume":"79","author":"Zhu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1989.66.3.1287","article-title":"Spontaneous injury in isolated sheep lungs: Role of perfusate leukocytes and platelets","author":"Pearse","year":"1985","journal-title":"J Appl Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114233","article-title":"Human platelets modulate edema formation in isolated rabbit lungs","volume":"84","author":"Heffner","year":"1989","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2243","article-title":"The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review","volume":"139","author":"Hui","year":"2011","journal-title":"Chest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00038.2015","article-title":"Platelets in pulmonary immune responses and inflammatory lung diseases","volume":"96","author":"Middleton","year":"2016","journal-title":"Physiol Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00023.2017","article-title":"Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse","volume":"313","author":"Lax","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.735922","article-title":"COVID-19 lung pathogenesis in SARS-CoV-2 autopsy cases","volume":"12","author":"Valdebenito","year":"2021","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047915","article-title":"Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: Therapeutic implications","volume":"142","author":"Archer","year":"2020","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: Different respiratory treatments for different phenotypes","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra07101","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30216-","article-title":"Endotheliopathy in COVID-19-Associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317803","article-title":"Platelet and vascular biomarkers associate with thrombosis and death in coronavirus disease","volume":"127","author":"Barrett","year":"2020","journal-title":"Circ Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17629","article-title":"Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts","volume":"195","author":"McCafferty","year":"2021","journal-title":"Br J Haematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007143","article-title":"Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19","volume":"6","author":"Garcia","year":"2022","journal-title":"Blood Adv"},{"key":"B52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12920-022-01222-y","article-title":"Co-Expression analysis to identify key modules and hub genes associated with COVID-19 in platelets","volume":"15","author":"Alarabi","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020201629","article-title":"Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: Report of the national institute for public health of the Netherlands","volume":"297","author":"Oudkerk","year":"2020","journal-title":"Radiology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1313LE","article-title":"Severe hypoxemia in early COVID-19 pneumonia","volume":"202","author":"Bhatia","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202003-0817LE","article-title":"COVID-19 does not lead to a \u201cTypical\u201d acute respiratory distress syndrome","volume":"201","author":"Gattinoni","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010186","article-title":"ICU Admission levels of endothelial biomarkers as predictors of mortality in critically ill COVID-19 patients","volume":"10","author":"Vassiliou","year":"2021","journal-title":"Cells"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15490","article-title":"Persistent endotheliopathy in the pathogenesis of long COVID syndrome","volume":"19","author":"Fogarty","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050907","article-title":"Endotheliopathy is induced by plasma from critically ill patients and associated with organ failure in severe COVID-19","volume":"142","author":"Rauch","year":"2020","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12860","article-title":"Mind the gap: Mechanisms regulating the endothelial barrier","volume":"222","author":"Radeva","year":"2018","journal-title":"Acta Physiol (Oxf)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab075","article-title":"Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectiousness among three immunocompromised patients: From prolonged viral shedding to SARS-CoV-2 superinfection","volume":"223","author":"Tarhini","year":"2021","journal-title":"J Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd772","article-title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","volume":"370","author":"Wajnberg","year":"2020","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf839","article-title":"COVID-19-Related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"de Melo","year":"2021","journal-title":"Sci Transl Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239309","article-title":"The contribution of endothelial dysfunction in systemic injury subsequent to SARS-CoV-2 infection","volume":"21","author":"Maiuolo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.219279","article-title":"Genetic ACE2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse","volume":"107","author":"Thomas","year":"2010","journal-title":"Circ Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116529","article-title":"Tissue factor pathway inhibitor reduces mortality from escherichia coli septic shock","volume":"91","author":"Creasey","year":"1993","journal-title":"J Clin Invest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI14137","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease","volume":"5","author":"Zhao","year":"2020","journal-title":"JCI Insight"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1164\/rccm.202008-3265OC","article-title":"Tissue-specific immunopathology in fatal COVID-19","volume":"203","author":"Dorward","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)13413-7","article-title":"Lung pathology of fatal severe acute respiratory syndrome","volume":"361","author":"Nicholls","year":"2003","journal-title":"Lancet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-Infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: Can we view them separately","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.08.017","article-title":"Interface between hemostasis and adaptive immunity","volume":"22","author":"Qu","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006680","article-title":"Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19","volume":"6","author":"Hottz","year":"2022","journal-title":"Blood Adv"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-862243","article-title":"Neutrophils: Back in the thrombosis spotlight","volume":"133","author":"Noubouossie","year":"2019","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-381400","article-title":"In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling","volume":"119","author":"Nishimura","year":"2012","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02517.x","article-title":"Platelets, inflammation and atherosclerosis","author":"Lindemann","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041607","article-title":"The platelet Napoleon complex-small cells, but big immune regulatory functions","volume":"37","author":"Morrell","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.04.006","article-title":"Association between hypoxemia and mortality in patients with COVID-19","volume":"95","author":"Xie","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2021.101004","article-title":"Severe pulmonary hypertension: An important sequel after severe post-acute COVID-19 pneumonia","volume":"47","author":"Cueto-Robledo","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the inflammatory response to severe COVID-19 illness","volume":"202","author":"McElvaney","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501924","article-title":"Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype","volume":"123","author":"Tyagi","year":"2014","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.16d14.x","article-title":"Platelet function in patients with obstructive sleep apnoea syndrome","volume":"16","author":"Sanner","year":"2000","journal-title":"Eur Respir J"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/18.3.188","article-title":"Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients","volume":"18","author":"R\u00e5ngemark","year":"1995","journal-title":"Sleep"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00020.2015","article-title":"Getting to the outer leaflet: Physiology of phosphatidylserine exposure at the plasma membrane","volume":"96","author":"Bevers","year":"2016","journal-title":"Physiol Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.04.106","article-title":"Oxalate impairs aminophospholipid translocase activity in renal epithelial cells Via oxidative stress: Implications for calcium oxalate urolithiasis","volume":"186","author":"Yu","year":"2011","journal-title":"J Urol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00029.2004","article-title":"Membrane microparticles: Two sides of the coin","volume":"20","author":"Hugel","year":"2005","journal-title":"Physiol (Bethesda)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000246775.14471.26","article-title":"Procoagulant microparticles: Disrupting the vascular homeostasis equation","volume":"26","author":"Morel","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Owens","year":"2011","journal-title":"Circ Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12173","article-title":"Binding of phosphatidylserine-positive microparticles by pbmcs classifies disease severity in COVID-19 patients","volume":"10","author":"Rausch","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2014.04.002","article-title":"Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine","volume":"28","author":"Burnouf","year":"2014","journal-title":"Blood Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.31770","article-title":"Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103369","article-title":"Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection","volume":"67","author":"Balbi","year":"2021","journal-title":"EBioMedicine"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-163832","article-title":"Megakaryocyte-derived microparticles: Direct visualization and distinction from platelet-derived microparticles","volume":"113","author":"Flaumenhaft","year":"2009","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00214.2009","article-title":"Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome","volume":"297","author":"Bastarache","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515536","article-title":"Influenza virus H1N1 activates platelets through Fc\u0393RIIA signaling and thrombin generation","volume":"123","author":"Boilard","year":"2014","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1038\/s41467-019-10360-4","article-title":"Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality Via CLEC5A\/TLR2","volume":"10","author":"Sung","year":"2019","journal-title":"Nat Commun"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315547","article-title":"Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report","volume":"41","author":"Rosell","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1021\/bi00043a004","article-title":"Phosphatidylethanolamine augments factor viia-tissue factor activity: Enhancement of sensitivity to phosphatidylserine","volume":"34","author":"Neuenschwander","year":"1995","journal-title":"Biochemistry"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/nm782","article-title":"Real-time In vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse","volume":"8","author":"Falati","year":"2002","journal-title":"Nat Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1160\/th07-11-0691","article-title":"Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells","volume":"100","author":"Aharon","year":"2008","journal-title":"Thromb Haemost"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008762","article-title":"Antibody-induced procoagulant platelets in severe COVID-19 infection","volume":"137","author":"Althaus","year":"2021","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr573","article-title":"Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: A pilot study","volume":"27","author":"Amabile","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-319552","article-title":"Antiplatelet therapy and outcome in COVID-19: the health outcome predictive evaluation registry","volume":"108","author":"Santoro","year":"2022","journal-title":"Heart"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26102","article-title":"Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis","volume":"96","author":"Meizlish","year":"2021","journal-title":"Am J Hematol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial","volume":"399","author":"Collaborative Group","year":"2022","journal-title":"Lancet"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa b by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041391","article-title":"P2Y12 inhibition beyond thrombosis: Effects on inflammation","volume":"21","author":"Mansour","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15517","article-title":"Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis","volume":"19","author":"Chow","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005292","article-title":"Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019","volume":"132","author":"Chow","year":"2021","journal-title":"Anesth Analg"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.802566","article-title":"Platelets and antiplatelet medication in COVID-19-Related thrombotic complications","volume":"8","author":"Schrottmaier","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.2910","article-title":"Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: A randomized clinical trial","volume":"327","author":"Bradbury","year":"2022","journal-title":"JAMA"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non-critically ill hospitalized patients with COVID-19: A randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"JAMA"},{"key":"B122","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11239-021-02507-2","article-title":"Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19","volume":"53","author":"Corrochano","year":"2022","journal-title":"J Thromb Thromb"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.02.006","article-title":"Thromboprophylaxis in patients with COVID-19: A brief update to the CHEST guideline and expert panel report","volume":"162","author":"Moores","year":"2022","journal-title":"Chest"},{"key":"B124","unstructured":"Living guidance for clinical management of COVID-192021"},{"key":"B125","unstructured":"COVID-19 rapid guideline: managing COVID-192022"},{"key":"B126","unstructured":"ASH guidelines on use of anticoagulation in patients with COVID-192022"},{"key":"B127","unstructured":"Coronavirus disease 2019 (COVID-19) treatment guideines2022"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.714426","article-title":"Serum metabolic profile in patients with long-covid (PASC) syndrome: Clinical implications","volume":"8","author":"Pasini","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B129","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s13054-020-03401-8","article-title":"Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis","volume":"24","author":"Kruse","year":"2020","journal-title":"Crit Care"},{"key":"B130","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jamcollsurg.2021.02.019","article-title":"Fibrinolysis shutdown in COVID-19: Clinical manifestations, molecular mechanisms, and therapeutic implications","volume":"232","author":"Meizoso","year":"2021","journal-title":"J Am Coll Surg"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.12.010","article-title":"Impaired fibrinolysis in critically ill COVID-19 patients","volume":"126","author":"Bachler","year":"2021","journal-title":"Br J Anaesth"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1126\/science.add4297","article-title":"Clues to long COVID","volume":"376","author":"Couzin-Frankel","year":"2022","journal-title":"Science"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1951","article-title":"Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites","volume":"101","author":"Shi","year":"2003","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03010.x","article-title":"Lactadherin blocks thrombosis and hemostasis In vivo: Correlation with platelet phosphatidylserine exposure","volume":"6","author":"Shi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-167148","article-title":"Lactadherin and clearance of platelet-derived microvesicles","volume":"113","author":"Dasgupta","year":"2009","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.955654\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T15:24:41Z","timestamp":1664465081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.955654\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":136,"alternative-id":["10.3389\/fimmu.2022.955654"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.955654","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"article-number":"955654"}}